Evidence map›Paper›PMID 27080443›Full record

ArticleScientific reports2016

MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.

B Vagaska, S E P New, C Alvarez-Gonzalez, F D'Acquisto, S G Gomez, N W Bulstrode, A Madrigal, P Ferretti

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Protective effects ofToxicology reports · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

B VagaskaStem Cells and Regenerative Section, UCL Institute of Child Health, London WC1N 1EH, UK.
S E P NewStem Cells and Regenerative Section, UCL Institute of Child Health, London WC1N 1EH, UK.
C Alvarez-GonzalezAnthony Nolan Research Institute, London NW3 2QG, UK.
F D'AcquistoWilliam Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
S G GomezAnthony Nolan Cell Therapy Centre, Nottingham NG11 8NS, UK.
N W BulstrodeDepartment of Plastic Surgery, Great Ormond St. Hospital for Children NHS Trust, London WC1N 3JH, UK.
A MadrigalAnthony Nolan Research Institute, London NW3 2QG, UK.
P FerrettiStem Cells and Regenerative Section, UCL Institute of Child Health, London WC1N 1EH, UK.

Funding

Medical Research Council G070089Wellcome Trust GR082557
6 · The paper itself

Abstract

Expression of major histocompatibility antigens class-2 (MHC-II) under non-inflammatory conditions is not usually associated with the nervous system. Comparative analysis of immunogenicity of human embryonic/fetal brain-derived neural stem cells (hNSCs) and human mesenchymal stem cells with neurogenic potential from umbilical cord (UC-MSCs) and paediatric adipose tissue (ADSCs), while highlighting differences in their immunogenicity, led us to discover subsets of neural cells co-expressing the neural marker SOX2 and MHC-II antigen in vivo during human CNS development. MHC-II proteins in hNSCs are functional, and differently regulated upon differentiation along different lineages. Mimicking an inflammatory response using the inflammatory cytokine IFNγ induced MHC-II up-regulation in both astrocytes and hNSCs, but not in UC-MSCs and ADSCs, either undifferentiated or differentiated, though IFNγ receptor expression was comparable. Together, hypoimmunogenicity of both UC-MSCs and ADSCs supports their suitability for allogeneic therapy, while significant immunogenicity of hNSCs and their progeny may at least in part underlie negative effects reported in some patients following embryonic neural cell grafts. Crucially, we show for the first time that MHC-II expression in developing human brains is not restricted to microglia as previously suggested, but is present in discrete subsets of neural progenitors and appears to be regulated independently of inflammatory stimuli.

Indexed as

Gene Expression Regulation, DevelopmentalAdipose TissueAstrocytesBiomarkersCell DifferentiationFetal BloodHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansInterferon-gammaNeural Stem CellsNeuronsReceptors, InterferonBiomarkersHistocompatibility Antigens Class IHistocompatibility Antigens Class IIInterferon-gammaReceptors, Interferon

Identifiers

PMID27080443
PMCPMC4832187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.